Hysteroscopic Myomectomy: Is There a Place for Pretreatment with GnRH Agonist?
Jude Ehiabhi Okohue
Citation Information :
Okohue JE. Hysteroscopic Myomectomy: Is There a Place for Pretreatment with GnRH Agonist?. World J Lap Surg 2009; 2 (2):53-56.
Copyright © 2009; The Author(s).
Uterine fibroids (also known as myomas or leiomyomas) are the commonest benign solid tumours found in the female genital tract. Hysteroscopic myomectomy presently represents the standard minimally invasive surgical procedure for treating submucous fibroids. Whether treatment with GnRH agonist before hysteroscopic myomectomy offers significant advantages is still a matter of debate.
A literature search was performed using Medline and the Google search engine, Springerlink and Highwire Press. A total of 11 articles were selected for review.
GnRH agonist use prior to hysteroscopic myomectomy probably has potential benefits in terms of reduction in size of the fibroid and improvement of hemoglobin level, especially in patients with underlying secondary anemia. However, universally acceptable guidelines on the indications and duration of pretreatment whether administered monthly or as daily injections are lacking. Large randomized controlled trials are urgently needed to clarify the gray areas.
Hysteroscopic myomectomy: A comprehensive review of surgical techniques. Hum Reprod Update 2008;14(2):101-19.
Hysteroscopic myomectomy. In: Hysteroscopy. Visual perspective of uterine anatomy, physiology and pathology. Diagnostic and operative hysteroscopy – Baggish MS, Valle RF Guedj H (Eds) 2007 (3rd ed). Philadephia: Lippincott Williams and Wilkins, a Wolters Kluwer business 385-404.
J Reprod Med 1996;41(7):483-90.
Fertility after hysteroscopic myomectomy. Hum reprod update 1995;1:81-90.
Factors in Fibroid growth. Review (100 refs) Baillieres Clin Obstet Gynaecol 1998;12(2):225-43.
Sex steroid receptors in human myometrium and fibroids: Changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clinical Endocrinol Metab 1998;83:4092-96.
Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: Results regarding the degree of intramural extension. Obstet Gynecol 1993;82:736-40.
A comparative study of three-dimensional saline infusion sonohysterography and diagnostic hysteroscopy for the classification of submucous fibroids. Hum Reprod 2005;20:253-57.
Hysteroscopic surgery. Best Pract Res Clin Obstet Gynaecol 2006;20:105-37.
Fertility after hysteroscopic myomectomy: Effect of intramural fibroids associated. Eur J Obstet Gynecol Reprod Biol 2000;88:85-90.
Hysteroscopic myomectomy: Our experience and review. JSLS 2003;7:39-48.
Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. Acta Obstet Gynecol Scand 2005;84:756-60.
Hysteroscopic myomectomy: Long-term effects on menstrual pattern and fertility. Obstet Gynecol 1999;94:341-47.
Preoperative evaluation of submucosal fibroid by virtual hysteroscopy. J Am Assoc Gynecol Laparosc 2004;11:404-09.
Excision of submucus fibroids with hysteroscopic control. Am J Obstet Gynecol 1976;126:95-99.
A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinising hormone - releasing hormone analogue. Am J Obstet Gynecol 1983;147-726.
GnRH agonist therapy before myomectomy or hysterectomy. J Minim Invasive Gynecol 2005;12:529-37.
Preoperative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001;2:CD000547.
Efficacy of preoperative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: A systematic review. BJOG 2002;109:1097-108.
GnRH agonist before surgery for uterine leiomyomas. A review. J Reprod Med 1996;41(6):415-21.
Hormonal treatment before surgical treatment of uterine leiomyomas. Surg Gynecol Obstet 1991;172(6):497-502.
Long-term follow-up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol 1999;106:700-05.
A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas. Akush Ginekol (Sophia) 1999;38(4):38-42.
GnRH agonist analogs and hysteroscopic resection of fibroids. Int J Gynaecol Obstet 1993;43:285-88.
Hysteroscopic Myomectomy. Min Inv Ther and Allied Tech 1994;3(4):203-05.
Role of leuprolide acetate depot in hysteroscopic surgery: A controlled study. Fertil Steril 1993;59:507-10.
Pre- and postoperative hormonal treatment in patients with hysteroscopic surgery. Contrib Gynecol Obstet 2000;20:1-12.
Hysteroscopic myomectomy. Curr Opin Obstet Gynecol 1995;7:311-16.
Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: Literature review. Hum Reprod 1998;13:2592-97.
Treatment with GnRH agonists before myomectomy and the risk of shortterm fibroid recurrence. Br J Obstet Gynaecol 1990;97:393-96.
Hysteroscopic treatment of menorrhagia associated with uterine leiofibroids. Obstet Gynecol 1993;81:716-20.
Complications in hysteroscopy: Prevention, treatment and legal risk. Curr Opin Obstet Gynecol 2002;14:409-15.
One-step hysteroscopic removal of sinking submucous fibroid in two infertile patients. Fertil Steril 2000;74:1035-38.
Single-stage total hysteroscopic myomectomies: indications, techniques, and results. Fertil Steril 1995;63:703-08.
Indications for hysterectomy. N Eng J Med 1993;328:856-60.
Hysteroscopic myomectomy: Fertility - preserving yet underutilized. J Fam Pract 2003;15(3):69-83.
Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist. Gynecol Oncol 1994;52:74-79.
Hysteroscopic myomectomy. Eur Clinics Obstet Gynecol 2007;3:17-23.
Publication bias. The triumph of hope over experience. JAMA 1992;267:411.